Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Patent
1990-06-27
1991-11-12
Ivy, C. Warren
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
544251, C07H 1906, C07D48702, A61K 31735
Patent
active
050649477
ABSTRACT:
Adenosine analogues which act selectively at adenosine receptors and which act in general as adenosine antagonists are disclosed. From in vitro studies it is known that specific physiological effects can be distinguished as a result of this selectivity and that adenosine receptor activity in vitro correlates with adenosine receptor activity in vivo. Pharmaceutical preparations of the subject compounds can be prepared on the basis of the selective binding activity of the compounds disclosed herein which can be expected to enhance certain physiological effects while minimizing others, such as decreasing blood pressure without decreasing heart rate.
REFERENCES:
patent: 3830795 (1974-08-01), Prasad et al.
patent: 3830796 (1974-08-01), Prasad
patent: 3931401 (1976-01-01), Prasad et al.
patent: 4007268 (1977-02-01), Voorhees
patent: 4388308 (1983-06-01), Hamilton
patent: 4728644 (1988-03-01), Yuki et al.
Spremulli et al., "Hemodynamic . . . , " CA 98: 172756 (1983).
Derwent Abstract 74-60887V.
Derwent Abstract 76-05684X.
Derwent Aabstract 74-32976V.
T. P. Johnston et al., J. Org. Chem., 27, 974 (1962).
Lentz Nelsen L.
Peet Norton P.
Chang Celia
Ivy C. Warren
Merrell Dow Pharmaceuticals Inc.
Sayles Michael J.
LandOfFree
Selective adenosine reseptor compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Selective adenosine reseptor compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Selective adenosine reseptor compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1014028